Gender medicine recognizes gender and sex as key health determinants that substantially modulate the epidemiology, pathophysiology, drug response, treatment adherence, and health outcomes of men and women, as well as individuals within the LGBTQ+ community. Gender differences are particularly evident in metabolic diseases such as type 2 diabetes and metabolic syndrome. The LGBTQ+ population faces unique challenges in terms of metabolic and cardiovascular health due to structural barriers and discrimination. It is essential that healthcare professionals receive training to provide appropriate and respectful care to people of all gender identities and sexual orientations.
Inclusive language and targeted training can help create a more welcoming and safer healthcare environment. Investing in research and education is crucial to ensure that everyone has access to personalized and equitable care.